Australia markets closed

Nephros, Inc. (NEPH)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.4100-0.0100 (-0.70%)
At close: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
12,208
9,975
10,404
8,561
10,334
Cost of revenue
5,735
5,244
4,661
3,648
4,250
Gross profit
6,473
4,731
5,743
4,913
6,084
Operating expenses
Research development
1,070
1,255
2,166
2,759
3,090
Selling general and administrative
7,894
7,593
7,710
6,466
6,119
Total operating expenses
9,188
9,066
10,078
9,417
9,395
Operating income or loss
-2,715
-4,335
-4,335
-4,504
-3,311
Interest expense
8
20
41
110
195
Total other income/expenses net
-21
64
499
77
102
Income before tax
-2,708
-4,277
-3,867
-4,526
-3,404
Income tax expense
-
-
-
0
-225
Income from continuing operations
-2,708
-4,277
-3,867
-4,526
-3,179
Net income
-4,888
-7,382
-4,107
-4,766
-3,420
Net income available to common shareholders
-4,888
-7,382
-4,107
-4,766
-3,420
Basic EPS
-
-0.73
-0.41
-0.52
-0.45
Diluted EPS
-
-0.73
-0.41
-0.52
-0.45
Basic average shares
-
10,297
10,018
9,079
7,542
Diluted average shares
-
10,297
10,018
9,079
7,542